XT
CVAC

XTX Topco’s CureVac CVAC Stock Holding History

XTX Topco’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,365
Closed -$83.1K – 2534
2024
Q4 		$83.1K Buy
24,365
+11,553
+90% +$33.3K 0.01% 1808
2024
Q3 		$37.7K Sell
12,812
-18,834
-60% -$62K ﹤0.01% 1739
2024
Q2 		$108K Buy
+31,646
New +$104K 0.01% 1403
2023
Q4 		– Sell
-19,320
Closed -$132K – 1687
2023
Q3 		$132K Buy
+19,320
New +$171K 0.02% 1143
2022
Q4 		– Sell
-12,040
Closed -$95K – 1199
2022
Q3 		$95K Buy
+12,040
New +$140K 0.02% 956
2021
Q3 		– Sell
-3,112
Closed -$229K – 750
2021
Q2 		$229K Buy
+3,112
New +$311K 0.08% 501

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

XTX Topco's CVAC Position: Q1 2025 in Review

XTX Topco sold out of CureVac (CVAC) in Q1 2025, closing a stake of 24,365 shares — an estimated $83.1K sold.

XTX Topco first reported a position in CVAC in Q2 2021 and held it in 6 quarters. The position peaked at $229K in Q2 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q1 2025.

  • XTX Topco reported no remaining CureVac position as of Q1 2025 after selling out during the quarter.
  • XTX Topco sold 24,365 CureVac shares in Q1 2025, an estimated $83.1K.
  • XTX Topco first reported a position in CureVac in Q2 2021 and held it in 6 quarters.
  • XTX Topco's CureVac position peaked at $229K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.